サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1719492

神経変性疾患治療薬の世界市場 2025～2029年

Global Neurodegenerative Diseases Therapeutics Market 2025-2029

出版日
発行
TechNavio
ページ情報
英文 251 Pages
納期
即納可能 即納可能とは
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
神経変性疾患治療薬の世界市場 2025～2029年
出版日: 2025年04月25日
発行: TechNavio
ページ情報: 英文 251 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

神経変性疾患治療薬市場は2024-2029年に248億5,220万米ドル、予測期間中のCAGRは9.1％で成長すると予測されます。

当レポートでは、神経変性疾患治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、強力な医薬品開発パイプライン、神経変性疾患に関する高い研究資金、高感度診断モダリティの利用可能性によって牽引されています。

市場範囲
基準年 2025
終了年 2029
予測期間 2025-2029
成長モメンタム 加速
前年比2025年 8%
CAGR 9.1%
増分額 248億5,220万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、高齢化人口の増加が今後数年間の神経変性疾患治療薬市場成長を牽引する主要因の一つであると指摘しています。また、神経変性疾患の遺伝的基盤および分子病態の理解向上と高い経済的負担は、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 Technavio分析

  • 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
  • インプットの重要性と差別化の要因
  • 混乱の要因
  • 促進要因と課題の影響

第3章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第4章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2024
  • 市場の見通し 2024-2029

第5章 市場規模実績

  • 神経変性疾患治療薬の世界市場 2019-2023
  • 適応症別セグメント分析 2019-2023
  • 薬剤クラス別セグメント分析 2019-2023
  • 投与経路別セグメント分析 2019-2023
  • エンドユーザー別セグメント分析 2019-2023
  • 地域別セグメント分析 2019-2023
  • 国別セグメント分析 2019-2023

第6章 定性分析

  • AIの影響：神経変性疾患治療薬の世界市場

第7章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第8章 市場セグメンテーション：適応症別

  • 市場セグメント
  • 比較：適応症別
  • 多発性硬化症：市場規模と予測 2024-2029
  • アルツハイマー病：市場規模と予測 2024-2029
  • パーキンソン病：市場規模と予測 2024-2029
  • ハンチントン病：市場規模と予測 2024-2029
  • その他：市場規模と予測 2024-2029
  • 市場機会：適応症別

第9章 市場セグメンテーション：薬剤クラス別

  • 市場セグメント
  • 比較：薬剤クラス別
  • 免疫調節薬：市場規模と予測 2024-2029
  • インターフェロン：市場規模と予測 2024-2029
  • 脱炭酸酵素阻害剤：市場規模と予測 2024-2029
  • ドーパミン作動薬：市場規模と予測 2024-2029
  • その他：市場規模と予測 2024-2029
  • 市場機会：薬剤クラス別

第10章 市場セグメンテーション：投与経路別

  • 市場セグメント
  • 比較：投与経路別
  • 経口：市場規模と予測 2024-2029
  • 注射：市場規模と予測 2024-2029
  • 経皮：市場規模と予測 2024-2029
  • 市場機会：投与経路別

第11章 市場セグメンテーション：エンドユーザー別

  • 市場セグメント
  • 比較：エンドユーザー別
  • 病院薬局：市場規模と予測 2024-2029
  • 小売薬局：市場規模と予測 2024-2029
  • オンライン薬局：市場規模と予測 2024-2029
  • 市場機会：エンドユーザー別

第12章 顧客情勢

  • 顧客情勢の概要

第13章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米：市場規模と予測 2024-2029
  • 欧州：市場規模と予測 2024-2029
  • アジア：市場規模と予測 2024-2029
  • 世界のその他の地域：市場規模と予測 2024-2029
  • 米国：市場規模と予測 2024-2029
  • ドイツ：市場規模と予測 2024-2029
  • カナダ：市場規模と予測 2024-2029
  • 中国：市場規模と予測 2024-2029
  • 日本：市場規模と予測 2024-2029
  • 英国：市場規模と予測 2024-2029
  • フランス：市場規模と予測 2024-2029
  • インド：市場規模と予測 2024-2029
  • イタリア：市場規模と予測 2024-2029
  • 韓国：市場規模と予測 2024-2029
  • 市場機会：地域情勢別

第14章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第15章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第16章 競合分析

  • 企業プロファイル
  • 企業ランキング指数
  • 企業の市場ポジショニング
  • AB Science SA
  • AbbVie Inc.
  • Acadia Pharmaceuticals Inc.
  • AstraZeneca Plc
  • Biogen Inc.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • H Lundbeck AS
  • Johnson and Johnson Services Inc.
  • Merck and Co. Inc.
  • Mitsubishi Chemical Corp.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Teva Pharmaceutical Industries Ltd.

第17章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Indication
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Drug Class
  • Exhibits7: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits8: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits9: Executive Summary - Chart on Incremental Growth
  • Exhibits10: Executive Summary - Data Table on Incremental Growth
  • Exhibits11: Executive Summary - Chart on Company Market Positioning
  • Exhibits12: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits13: Overview on criticality of inputs and factors of differentiation
  • Exhibits14: Overview on factors of disruption
  • Exhibits15: Impact of drivers and challenges in 2024 and 2029
  • Exhibits16: Parent Market
  • Exhibits17: Data Table on - Parent Market
  • Exhibits18: Market characteristics analysis
  • Exhibits19: Value chain analysis
  • Exhibits20: Offerings of companies included in the market definition
  • Exhibits21: Market segments
  • Exhibits22: Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits23: Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Exhibits24: Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits25: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
  • Exhibits26: Historic Market Size - Data Table on Global Neurodegenerative Diseases Therapeutics Market 2019 - 2023 ($ million)
  • Exhibits27: Historic Market Size - Indication Segment 2019 - 2023 ($ million)
  • Exhibits28: Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • Exhibits29: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
  • Exhibits30: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • Exhibits31: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • Exhibits32: Historic Market Size - Country Segment 2019 - 2023 ($ million)
  • Exhibits33: Five forces analysis - Comparison between 2024 and 2029
  • Exhibits34: Bargaining power of buyers - Impact of key factors 2024 and 2029
  • Exhibits35: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • Exhibits36: Threat of new entrants - Impact of key factors in 2024 and 2029
  • Exhibits37: Threat of substitutes - Impact of key factors in 2024 and 2029
  • Exhibits38: Threat of rivalry - Impact of key factors in 2024 and 2029
  • Exhibits39: Chart on Market condition - Five forces 2024 and 2029
  • Exhibits40: Chart on Indication - Market share 2024-2029 (%)
  • Exhibits41: Data Table on Indication - Market share 2024-2029 (%)
  • Exhibits42: Chart on Comparison by Indication
  • Exhibits43: Data Table on Comparison by Indication
  • Exhibits44: Chart on Multiple sclerosis - Market size and forecast 2024-2029 ($ million)
  • Exhibits45: Data Table on Multiple sclerosis - Market size and forecast 2024-2029 ($ million)
  • Exhibits46: Chart on Multiple sclerosis - Year-over-year growth 2024-2029 (%)
  • Exhibits47: Data Table on Multiple sclerosis - Year-over-year growth 2024-2029 (%)
  • Exhibits48: Chart on Alzheimers disease - Market size and forecast 2024-2029 ($ million)
  • Exhibits49: Data Table on Alzheimers disease - Market size and forecast 2024-2029 ($ million)
  • Exhibits50: Chart on Alzheimers disease - Year-over-year growth 2024-2029 (%)
  • Exhibits51: Data Table on Alzheimers disease - Year-over-year growth 2024-2029 (%)
  • Exhibits52: Chart on Parkinsons disease - Market size and forecast 2024-2029 ($ million)
  • Exhibits53: Data Table on Parkinsons disease - Market size and forecast 2024-2029 ($ million)
  • Exhibits54: Chart on Parkinsons disease - Year-over-year growth 2024-2029 (%)
  • Exhibits55: Data Table on Parkinsons disease - Year-over-year growth 2024-2029 (%)
  • Exhibits56: Chart on Huntingtons disease - Market size and forecast 2024-2029 ($ million)
  • Exhibits57: Data Table on Huntingtons disease - Market size and forecast 2024-2029 ($ million)
  • Exhibits58: Chart on Huntingtons disease - Year-over-year growth 2024-2029 (%)
  • Exhibits59: Data Table on Huntingtons disease - Year-over-year growth 2024-2029 (%)
  • Exhibits60: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits61: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits62: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits63: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits64: Market opportunity by Indication ($ million)
  • Exhibits65: Data Table on Market opportunity by Indication ($ million)
  • Exhibits66: Chart on Drug Class - Market share 2024-2029 (%)
  • Exhibits67: Data Table on Drug Class - Market share 2024-2029 (%)
  • Exhibits68: Chart on Comparison by Drug Class
  • Exhibits69: Data Table on Comparison by Drug Class
  • Exhibits70: Chart on Immunomodulators - Market size and forecast 2024-2029 ($ million)
  • Exhibits71: Data Table on Immunomodulators - Market size and forecast 2024-2029 ($ million)
  • Exhibits72: Chart on Immunomodulators - Year-over-year growth 2024-2029 (%)
  • Exhibits73: Data Table on Immunomodulators - Year-over-year growth 2024-2029 (%)
  • Exhibits74: Chart on Interferons - Market size and forecast 2024-2029 ($ million)
  • Exhibits75: Data Table on Interferons - Market size and forecast 2024-2029 ($ million)
  • Exhibits76: Chart on Interferons - Year-over-year growth 2024-2029 (%)
  • Exhibits77: Data Table on Interferons - Year-over-year growth 2024-2029 (%)
  • Exhibits78: Chart on Decarboxylase inhibitors - Market size and forecast 2024-2029 ($ million)
  • Exhibits79: Data Table on Decarboxylase inhibitors - Market size and forecast 2024-2029 ($ million)
  • Exhibits80: Chart on Decarboxylase inhibitors - Year-over-year growth 2024-2029 (%)
  • Exhibits81: Data Table on Decarboxylase inhibitors - Year-over-year growth 2024-2029 (%)
  • Exhibits82: Chart on Dopamine agonists - Market size and forecast 2024-2029 ($ million)
  • Exhibits83: Data Table on Dopamine agonists - Market size and forecast 2024-2029 ($ million)
  • Exhibits84: Chart on Dopamine agonists - Year-over-year growth 2024-2029 (%)
  • Exhibits85: Data Table on Dopamine agonists - Year-over-year growth 2024-2029 (%)
  • Exhibits86: Chart on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits87: Data Table on Others - Market size and forecast 2024-2029 ($ million)
  • Exhibits88: Chart on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits89: Data Table on Others - Year-over-year growth 2024-2029 (%)
  • Exhibits90: Market opportunity by Drug Class ($ million)
  • Exhibits91: Data Table on Market opportunity by Drug Class ($ million)
  • Exhibits92: Chart on Route of Administration - Market share 2024-2029 (%)
  • Exhibits93: Data Table on Route of Administration - Market share 2024-2029 (%)
  • Exhibits94: Chart on Comparison by Route of Administration
  • Exhibits95: Data Table on Comparison by Route of Administration
  • Exhibits96: Chart on Oral - Market size and forecast 2024-2029 ($ million)
  • Exhibits97: Data Table on Oral - Market size and forecast 2024-2029 ($ million)
  • Exhibits98: Chart on Oral - Year-over-year growth 2024-2029 (%)
  • Exhibits99: Data Table on Oral - Year-over-year growth 2024-2029 (%)
  • Exhibits100: Chart on Injection - Market size and forecast 2024-2029 ($ million)
  • Exhibits101: Data Table on Injection - Market size and forecast 2024-2029 ($ million)
  • Exhibits102: Chart on Injection - Year-over-year growth 2024-2029 (%)
  • Exhibits103: Data Table on Injection - Year-over-year growth 2024-2029 (%)
  • Exhibits104: Chart on Transdermal - Market size and forecast 2024-2029 ($ million)
  • Exhibits105: Data Table on Transdermal - Market size and forecast 2024-2029 ($ million)
  • Exhibits106: Chart on Transdermal - Year-over-year growth 2024-2029 (%)
  • Exhibits107: Data Table on Transdermal - Year-over-year growth 2024-2029 (%)
  • Exhibits108: Market opportunity by Route of Administration ($ million)
  • Exhibits109: Data Table on Market opportunity by Route of Administration ($ million)
  • Exhibits110: Chart on End-user - Market share 2024-2029 (%)
  • Exhibits111: Data Table on End-user - Market share 2024-2029 (%)
  • Exhibits112: Chart on Comparison by End-user
  • Exhibits113: Data Table on Comparison by End-user
  • Exhibits114: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits115: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits116: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits117: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits118: Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits119: Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits120: Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits121: Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits122: Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits123: Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
  • Exhibits124: Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits125: Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
  • Exhibits126: Market opportunity by End-user ($ million)
  • Exhibits127: Data Table on Market opportunity by End-user ($ million)
  • Exhibits128: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits129: Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits130: Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • Exhibits131: Chart on Geographic comparison
  • Exhibits132: Data Table on Geographic comparison
  • Exhibits133: Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits134: Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Exhibits135: Chart on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits136: Data Table on North America - Year-over-year growth 2024-2029 (%)
  • Exhibits137: Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits138: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Exhibits139: Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits140: Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • Exhibits141: Chart on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits142: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
  • Exhibits143: Chart on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits144: Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • Exhibits145: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits146: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
  • Exhibits147: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits148: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • Exhibits149: Chart on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits150: Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Exhibits151: Chart on US - Year-over-year growth 2024-2029 (%)
  • Exhibits152: Data Table on US - Year-over-year growth 2024-2029 (%)
  • Exhibits153: Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits154: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Exhibits155: Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits156: Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • Exhibits157: Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits158: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Exhibits159: Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits160: Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • Exhibits161: Chart on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits162: Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Exhibits163: Chart on China - Year-over-year growth 2024-2029 (%)
  • Exhibits164: Data Table on China - Year-over-year growth 2024-2029 (%)
  • Exhibits165: Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits166: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Exhibits167: Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits168: Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • Exhibits169: Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits170: Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Exhibits171: Chart on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits172: Data Table on UK - Year-over-year growth 2024-2029 (%)
  • Exhibits173: Chart on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits174: Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Exhibits175: Chart on France - Year-over-year growth 2024-2029 (%)
  • Exhibits176: Data Table on France - Year-over-year growth 2024-2029 (%)
  • Exhibits177: Chart on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits178: Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Exhibits179: Chart on India - Year-over-year growth 2024-2029 (%)
  • Exhibits180: Data Table on India - Year-over-year growth 2024-2029 (%)
  • Exhibits181: Chart on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits182: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
  • Exhibits183: Chart on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits184: Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • Exhibits185: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits186: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
  • Exhibits187: Chart on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits188: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • Exhibits189: Market opportunity By Geographical Landscape ($ million)
  • Exhibits190: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits191: Impact of drivers and challenges in 2024 and 2029
  • Exhibits192: Overview on criticality of inputs and factors of differentiation
  • Exhibits193: Overview on factors of disruption
  • Exhibits194: Impact of key risks on business
  • Exhibits195: Companies covered
  • Exhibits196: Company ranking index
  • Exhibits197: Matrix on companies position and classification
  • Exhibits198: AB Science SA - Overview
  • Exhibits199: AB Science SA - Product / Service
  • Exhibits200: AB Science SA - Key offerings
  • Exhibits201: SWOT
  • Exhibits202: AbbVie Inc. - Overview
  • Exhibits203: AbbVie Inc. - Product / Service
  • Exhibits204: AbbVie Inc. - Key news
  • Exhibits205: AbbVie Inc. - Key offerings
  • Exhibits206: SWOT
  • Exhibits207: Acadia Pharmaceuticals Inc. - Overview
  • Exhibits208: Acadia Pharmaceuticals Inc. - Product / Service
  • Exhibits209: Acadia Pharmaceuticals Inc. - Key offerings
  • Exhibits210: SWOT
  • Exhibits211: AstraZeneca Plc - Overview
  • Exhibits212: AstraZeneca Plc - Product / Service
  • Exhibits213: AstraZeneca Plc - Key news
  • Exhibits214: AstraZeneca Plc - Key offerings
  • Exhibits215: SWOT
  • Exhibits216: Biogen Inc. - Overview
  • Exhibits217: Biogen Inc. - Product / Service
  • Exhibits218: Biogen Inc. - Key offerings
  • Exhibits219: SWOT
  • Exhibits220: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits221: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits222: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits223: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits224: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits225: SWOT
  • Exhibits226: GlaxoSmithKline Plc - Overview
  • Exhibits227: GlaxoSmithKline Plc - Business segments
  • Exhibits228: GlaxoSmithKline Plc - Key news
  • Exhibits229: GlaxoSmithKline Plc - Key offerings
  • Exhibits230: GlaxoSmithKline Plc - Segment focus
  • Exhibits231: SWOT
  • Exhibits232: H Lundbeck AS - Overview
  • Exhibits233: H Lundbeck AS - Product / Service
  • Exhibits234: H Lundbeck AS - Key offerings
  • Exhibits235: SWOT
  • Exhibits236: Johnson and Johnson Services Inc. - Overview
  • Exhibits237: Johnson and Johnson Services Inc. - Business segments
  • Exhibits238: Johnson and Johnson Services Inc. - Key news
  • Exhibits239: Johnson and Johnson Services Inc. - Key offerings
  • Exhibits240: Johnson and Johnson Services Inc. - Segment focus
  • Exhibits241: SWOT
  • Exhibits242: Merck and Co. Inc. - Overview
  • Exhibits243: Merck and Co. Inc. - Business segments
  • Exhibits244: Merck and Co. Inc. - Key news
  • Exhibits245: Merck and Co. Inc. - Key offerings
  • Exhibits246: Merck and Co. Inc. - Segment focus
  • Exhibits247: SWOT
  • Exhibits248: Mitsubishi Chemical Corp. - Overview
  • Exhibits249: Mitsubishi Chemical Corp. - Business segments
  • Exhibits250: Mitsubishi Chemical Corp. - Key offerings
  • Exhibits251: Mitsubishi Chemical Corp. - Segment focus
  • Exhibits252: SWOT
  • Exhibits253: Novartis AG - Overview
  • Exhibits254: Novartis AG - Business segments
  • Exhibits255: Novartis AG - Key news
  • Exhibits256: Novartis AG - Key offerings
  • Exhibits257: Novartis AG - Segment focus
  • Exhibits258: SWOT
  • Exhibits259: Pfizer Inc. - Overview
  • Exhibits260: Pfizer Inc. - Product / Service
  • Exhibits261: Pfizer Inc. - Key news
  • Exhibits262: Pfizer Inc. - Key offerings
  • Exhibits263: SWOT
  • Exhibits264: Sanofi SA - Overview
  • Exhibits265: Sanofi SA - Business segments
  • Exhibits266: Sanofi SA - Key news
  • Exhibits267: Sanofi SA - Key offerings
  • Exhibits268: Sanofi SA - Segment focus
  • Exhibits269: SWOT
  • Exhibits270: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits271: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits272: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits273: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits274: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits275: SWOT
  • Exhibits276: Inclusions checklist
  • Exhibits277: Exclusions checklist
  • Exhibits278: Currency conversion rates for US$
  • Exhibits279: Research methodology
  • Exhibits280: Information sources
  • Exhibits281: Data validation
  • Exhibits282: Validation techniques employed for market sizing
  • Exhibits283: Data synthesis
  • Exhibits284: 360 degree market analysis
  • Exhibits285: List of abbreviations
目次
Product Code: IRTNTR73294

The neurodegenerative diseases therapeutics market is forecasted to grow by USD 24852.2 mn during 2024-2029, accelerating at a CAGR of 9.1% during the forecast period. The report on the neurodegenerative diseases therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by strong drug development pipeline, high research funding on neurodegenerative diseases, and availability of highly sensitive diagnostic modalities.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20258%
CAGR9.1%
Incremental Value$24852.2 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's neurodegenerative diseases therapeutics market is segmented as below:

By Indication

    • Multiple sclerosis
    • Alzheimers disease
    • Parkinsons disease
    • Huntingtons disease
    • Others

By Drug Class

    • Immunomodulators
    • Interferons
    • Decarboxylase inhibitors
    • Dopamine agonists
    • Others

By Route Of Administration

    • Oral
    • Injection
    • Transdermal

By End-user

    • Hospital pharmacy
    • Retail pharmacy
    • Online pharmacy

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the increase in aging population as one of the prime reasons driving the neurodegenerative diseases therapeutics market growth during the next few years. Also, improved understanding of genetic basis and molecular pathology of neurodegenerative diseases and high economic burden will lead to sizable demand in the market.

The report on the neurodegenerative diseases therapeutics market covers the following areas:

    • Neurodegenerative Diseases Therapeutics Market sizing
    • Neurodegenerative Diseases Therapeutics Market forecast
    • Neurodegenerative Diseases Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neurodegenerative diseases therapeutics market vendors that include AB Science SA, AbbVie Inc., Acadia Pharmaceuticals Inc., AstraZeneca Plc, Biogen Inc., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, H Lundbeck AS, Johnson and Johnson Services Inc., Merck and Co. Inc., Mitsubishi Chemical Corp., Novartis AG, Pfizer Inc., Sanofi SA, and Teva Pharmaceutical Industries Ltd.. Also, the neurodegenerative diseases therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Indication
    • Executive Summary - Chart on Market Segmentation by Drug Class
    • Executive Summary - Chart on Market Segmentation by Route of Administration
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Neurodegenerative Diseases Therapeutics Market 2019 - 2023
    • Historic Market Size - Data Table on Global Neurodegenerative Diseases Therapeutics Market 2019 - 2023 ($ million)
  • 5.2 Indication segment analysis 2019 - 2023
    • Historic Market Size - Indication Segment 2019 - 2023 ($ million)
  • 5.3 Drug Class segment analysis 2019 - 2023
    • Historic Market Size - Drug Class Segment 2019 - 2023 ($ million)
  • 5.4 Route of Administration segment analysis 2019 - 2023
    • Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
  • 5.5 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.6 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.7 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI in global neurodegenerative diseases therapeutics market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Indication

  • 8.1 Market segments
    • Chart on Indication - Market share 2024-2029 (%)
    • Data Table on Indication - Market share 2024-2029 (%)
  • 8.2 Comparison by Indication
    • Chart on Comparison by Indication
    • Data Table on Comparison by Indication
  • 8.3 Multiple sclerosis - Market size and forecast 2024-2029
    • Chart on Multiple sclerosis - Market size and forecast 2024-2029 ($ million)
    • Data Table on Multiple sclerosis - Market size and forecast 2024-2029 ($ million)
    • Chart on Multiple sclerosis - Year-over-year growth 2024-2029 (%)
    • Data Table on Multiple sclerosis - Year-over-year growth 2024-2029 (%)
  • 8.4 Alzheimers disease - Market size and forecast 2024-2029
    • Chart on Alzheimers disease - Market size and forecast 2024-2029 ($ million)
    • Data Table on Alzheimers disease - Market size and forecast 2024-2029 ($ million)
    • Chart on Alzheimers disease - Year-over-year growth 2024-2029 (%)
    • Data Table on Alzheimers disease - Year-over-year growth 2024-2029 (%)
  • 8.5 Parkinsons disease - Market size and forecast 2024-2029
    • Chart on Parkinsons disease - Market size and forecast 2024-2029 ($ million)
    • Data Table on Parkinsons disease - Market size and forecast 2024-2029 ($ million)
    • Chart on Parkinsons disease - Year-over-year growth 2024-2029 (%)
    • Data Table on Parkinsons disease - Year-over-year growth 2024-2029 (%)
  • 8.6 Huntingtons disease - Market size and forecast 2024-2029
    • Chart on Huntingtons disease - Market size and forecast 2024-2029 ($ million)
    • Data Table on Huntingtons disease - Market size and forecast 2024-2029 ($ million)
    • Chart on Huntingtons disease - Year-over-year growth 2024-2029 (%)
    • Data Table on Huntingtons disease - Year-over-year growth 2024-2029 (%)
  • 8.7 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 8.8 Market opportunity by Indication
    • Market opportunity by Indication ($ million)
    • Data Table on Market opportunity by Indication ($ million)

9 Market Segmentation by Drug Class

  • 9.1 Market segments
    • Chart on Drug Class - Market share 2024-2029 (%)
    • Data Table on Drug Class - Market share 2024-2029 (%)
  • 9.2 Comparison by Drug Class
    • Chart on Comparison by Drug Class
    • Data Table on Comparison by Drug Class
  • 9.3 Immunomodulators - Market size and forecast 2024-2029
    • Chart on Immunomodulators - Market size and forecast 2024-2029 ($ million)
    • Data Table on Immunomodulators - Market size and forecast 2024-2029 ($ million)
    • Chart on Immunomodulators - Year-over-year growth 2024-2029 (%)
    • Data Table on Immunomodulators - Year-over-year growth 2024-2029 (%)
  • 9.4 Interferons - Market size and forecast 2024-2029
    • Chart on Interferons - Market size and forecast 2024-2029 ($ million)
    • Data Table on Interferons - Market size and forecast 2024-2029 ($ million)
    • Chart on Interferons - Year-over-year growth 2024-2029 (%)
    • Data Table on Interferons - Year-over-year growth 2024-2029 (%)
  • 9.5 Decarboxylase inhibitors - Market size and forecast 2024-2029
    • Chart on Decarboxylase inhibitors - Market size and forecast 2024-2029 ($ million)
    • Data Table on Decarboxylase inhibitors - Market size and forecast 2024-2029 ($ million)
    • Chart on Decarboxylase inhibitors - Year-over-year growth 2024-2029 (%)
    • Data Table on Decarboxylase inhibitors - Year-over-year growth 2024-2029 (%)
  • 9.6 Dopamine agonists - Market size and forecast 2024-2029
    • Chart on Dopamine agonists - Market size and forecast 2024-2029 ($ million)
    • Data Table on Dopamine agonists - Market size and forecast 2024-2029 ($ million)
    • Chart on Dopamine agonists - Year-over-year growth 2024-2029 (%)
    • Data Table on Dopamine agonists - Year-over-year growth 2024-2029 (%)
  • 9.7 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 9.8 Market opportunity by Drug Class
    • Market opportunity by Drug Class ($ million)
    • Data Table on Market opportunity by Drug Class ($ million)

10 Market Segmentation by Route of Administration

  • 10.1 Market segments
    • Chart on Route of Administration - Market share 2024-2029 (%)
    • Data Table on Route of Administration - Market share 2024-2029 (%)
  • 10.2 Comparison by Route of Administration
    • Chart on Comparison by Route of Administration
    • Data Table on Comparison by Route of Administration
  • 10.3 Oral - Market size and forecast 2024-2029
    • Chart on Oral - Market size and forecast 2024-2029 ($ million)
    • Data Table on Oral - Market size and forecast 2024-2029 ($ million)
    • Chart on Oral - Year-over-year growth 2024-2029 (%)
    • Data Table on Oral - Year-over-year growth 2024-2029 (%)
  • 10.4 Injection - Market size and forecast 2024-2029
    • Chart on Injection - Market size and forecast 2024-2029 ($ million)
    • Data Table on Injection - Market size and forecast 2024-2029 ($ million)
    • Chart on Injection - Year-over-year growth 2024-2029 (%)
    • Data Table on Injection - Year-over-year growth 2024-2029 (%)
  • 10.5 Transdermal - Market size and forecast 2024-2029
    • Chart on Transdermal - Market size and forecast 2024-2029 ($ million)
    • Data Table on Transdermal - Market size and forecast 2024-2029 ($ million)
    • Chart on Transdermal - Year-over-year growth 2024-2029 (%)
    • Data Table on Transdermal - Year-over-year growth 2024-2029 (%)
  • 10.6 Market opportunity by Route of Administration
    • Market opportunity by Route of Administration ($ million)
    • Data Table on Market opportunity by Route of Administration ($ million)

11 Market Segmentation by End-user

  • 11.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 11.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 11.3 Hospital pharmacy - Market size and forecast 2024-2029
    • Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ million)
    • Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
    • Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
  • 11.4 Retail pharmacy - Market size and forecast 2024-2029
    • Chart on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Retail pharmacy - Market size and forecast 2024-2029 ($ million)
    • Chart on Retail pharmacy - Year-over-year growth 2024-2029 (%)
    • Data Table on Retail pharmacy - Year-over-year growth 2024-2029 (%)
  • 11.5 Online pharmacy - Market size and forecast 2024-2029
    • Chart on Online pharmacy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ million)
    • Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
    • Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
  • 11.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

12 Customer Landscape

  • 12.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

13 Geographic Landscape

  • 13.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 13.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 13.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 13.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 13.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 13.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 13.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 13.8 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 13.9 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 13.10 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 13.11 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 13.12 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 13.13 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 13.14 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 13.15 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 13.16 South Korea - Market size and forecast 2024-2029
    • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
    • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
    • Chart on South Korea - Year-over-year growth 2024-2029 (%)
    • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • 13.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

14 Drivers, Challenges, and Opportunity/Restraints

  • 14.1 Market drivers
  • 14.2 Market challenges
  • 14.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 14.4 Market opportunities/restraints

15 Competitive Landscape

  • 15.1 Overview
  • 15.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 15.3 Landscape disruption
    • Overview on factors of disruption
  • 15.4 Industry risks
    • Impact of key risks on business

16 Competitive Analysis

  • 16.1 Companies profiled
    • Companies covered
  • 16.2 Company ranking index
    • Company ranking index
  • 16.3 Market positioning of companies
    • Matrix on companies position and classification
  • 16.4 AB Science SA
    • AB Science SA - Overview
    • AB Science SA - Product / Service
    • AB Science SA - Key offerings
    • SWOT
  • 16.5 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
    • SWOT
  • 16.6 Acadia Pharmaceuticals Inc.
    • Acadia Pharmaceuticals Inc. - Overview
    • Acadia Pharmaceuticals Inc. - Product / Service
    • Acadia Pharmaceuticals Inc. - Key offerings
    • SWOT
  • 16.7 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
    • SWOT
  • 16.8 Biogen Inc.
    • Biogen Inc. - Overview
    • Biogen Inc. - Product / Service
    • Biogen Inc. - Key offerings
    • SWOT
  • 16.9 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
    • SWOT
  • 16.10 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
    • SWOT
  • 16.11 H Lundbeck AS
    • H Lundbeck AS - Overview
    • H Lundbeck AS - Product / Service
    • H Lundbeck AS - Key offerings
    • SWOT
  • 16.12 Johnson and Johnson Services Inc.
    • Johnson and Johnson Services Inc. - Overview
    • Johnson and Johnson Services Inc. - Business segments
    • Johnson and Johnson Services Inc. - Key news
    • Johnson and Johnson Services Inc. - Key offerings
    • Johnson and Johnson Services Inc. - Segment focus
    • SWOT
  • 16.13 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
    • SWOT
  • 16.14 Mitsubishi Chemical Corp.
    • Mitsubishi Chemical Corp. - Overview
    • Mitsubishi Chemical Corp. - Business segments
    • Mitsubishi Chemical Corp. - Key offerings
    • Mitsubishi Chemical Corp. - Segment focus
    • SWOT
  • 16.15 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 16.16 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 16.17 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
    • SWOT
  • 16.18 Teva Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd. - Overview
    • Teva Pharmaceutical Industries Ltd. - Business segments
    • Teva Pharmaceutical Industries Ltd. - Key news
    • Teva Pharmaceutical Industries Ltd. - Key offerings
    • Teva Pharmaceutical Industries Ltd. - Segment focus
    • SWOT

17 Appendix

  • 17.1 Scope of the report
  • 17.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 17.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 17.4 Research methodology
    • Research methodology
  • 17.5 Data procurement
    • Information sources
  • 17.6 Data validation
    • Data validation
  • 17.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 17.8 Data synthesis
    • Data synthesis
  • 17.9 360 degree market analysis
    • 360 degree market analysis
  • 17.10 List of abbreviations
    • List of abbreviations